GSK said it is holding steady in the face of ongoing regulatory and potential political pressures on its vaccines franchise, ...

Novo Nordisk reports 26% sales growth in 2024, but projects lower 2025 growth of 16-24%. Full-year Wegovy sales up 86%, ...

Amgen's obesity drug AMG-513 on clinical hold; company reaffirms obesity market ambitions while advancing MariTide program ...

Robert F. Kennedy Jr. advances toward Senate confirmation despite vaccine controversy, as key skeptic Sen. Bill Cassidy backs ...

Johnson & Johnson has asked a federal district court to expedite its decision in a case over the company’s proposed 340B ...

China tensions, following US restrictions on Chinese rivals BGI and MGI. Illumina says China accounts for 7% of Q3 revenue.

At long last, the FDA approved Supernus Pharmaceuticals’ Parkinson’s disease treatment, which will be marketed as Onapgo.

Bicycle Health, a telehealth provider for opioid use disorder treatment led by Ankit Gupta, turns profitable and raises ...

Bicycle Health, a telehealth provider for opioid use disorder treatment led by Ankit Gupta, turns profitable and raises $16.5M. Company has treated 40,000+ patients.

Despite uncertainty around HPV vaccine sales in China, Merck CEO Robert Davis said he’s confident the company can “deliver strong growth” and navigate Keytruda’s impending patent cliff.

Turnstone Biologics halts TIL therapy studies, seeks strategic alternatives. GH Research plans $150M offering. Auron gets $27M Series B. Akribion launches. Enveric signs deal. Valerio stops trials.

Alzheimer’s disease has afflicted Hannah Richardson’s family for generations. A rare genetic mutation, passed down from her great-grandmother, has struck her relatives with the first signs of memory ...